Eagle Pharmaceuticals Inc (EGRX) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering EGRX.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 27 weeks, EGRX's average price target has gone down $1.33.
EGRX reports an average of 7.65% for its upside potential over the past 50 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
EGRX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Eagle Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 13.38% of Pharmaceutical Products stocks.
- The average analyst price target of EGRX is greater than 85.17% of stocks in the small market cap category.
- Eagle Pharmaceuticals Inc's variance in analysts' estimates is lower than 81.73% of Pharmaceutical Products stocks.
- Eagle Pharmaceuticals Inc's number of analysts covering the stock is greater than 22.88% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, NEOG, ANIP and SUPN are the three stocks most similar to Eagle Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Is EGRX a Buy, Hold or Sell? See the POWR Ratings now!